Press release
A Deep Dive into Candidiasis Therapeutics Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034
Candidiasis Therapeutics Market Size
The candidiasis therapeutics market has grown at a steady pace in recent years. It is expected to expand from $3.19 billion in 2024 to $3.3 billion in 2025, achieving a CAGR of 3.4%. Growth in this market has been influenced by a rise in candidiasis cases, antibiotic usage and resistance, hospital-acquired infections, evolving fungal resistance patterns, and awareness campaigns.
The candidiasis therapeutics market is expected to grow to $3.83 billion by 2029, with a CAGR of 3.8%. Growth is driven by precision medicine, antifungal stewardship programs, and efforts against antifungal resistance. Trends include drug delivery advancements, telemedicine integration, and collaborative research.
What Is Contributing to the Growth of the Candidiasis Therapeutics Market?
The growing incidence of fungal infections is expected to drive the growth of the candidiasis therapeutics market. Fungal infections, particularly those caused by Candida species, are becoming more common, especially among immunocompromised individuals. The University of Minnesota reported that fungal diseases cause over 3.75 million deaths annually, creating a need for effective treatments. Therefore, the rise in fungal infections will contribute to the demand for candidiasis therapeutics.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13182&type=smp
Which Key Market Leaders Are Driving Candidiasis Therapeutics Industry Growth?
Major companies operating in the candidiasis therapeutics market report are Pfizer Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc., GSK plc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Cipla Inc., Bruker Corporation, Lupin Limited, Galapagos NV, Basilea Pharmaceutica Ltd., WOCKHARDT Limited, Pacgen Life Science Corporation, Cidara Therapeutics Inc., Ablynx NV, Amplyx Pharmaceuticals Inc., NovaDigm Therapeutics Inc., SCYNEXIS Inc., Medivir AB, Mycovia Pharmaceuticals Inc., NovaBiotics Inc., Matinas BioPharma Holdings Inc.
What Are the Emerging Trends in the Candidiasis Therapeutics Industry?
In the candidiasis therapeutics market, firms are developing groundbreaking medications like BREXAFEMME (ibrexafungerp tablets) to combat recurrent vulvovaginal candidiasis (RVVC) in adult women. BREXAFEMME is a non-azole oral treatment designed for vulvovaginal candidiasis (VVC) and the reduction of RVVC recurrence. For instance, in December 2022, Scynexis Inc., a US-based pharmaceutical company, secured FDA approval for BREXAFEMME to treat VVC and minimize recurrent infections. This medication inhibits Candida albicans growth, offering a safe and effective therapeutic solution available only by prescription, with a recommended dosage of one 150-mg capsule taken orally once daily.
What Are the Main Segments in the Candidiasis Therapeutics Market?
The candidiasis therapeutics market covered in this report is segmented -
1) By Treatment Type: Medication, Surgery, Other Treatments
2) By Anatomy Type: Oral Candidiasis, Vulvovaginal Candidiasis, Cutaneous Candidiasis, Invasive Candidiasis, Systemic Candidiasis
3) By Mode Of Administration: Injectable, Oral, Other Mode Of Administrations
4) By Patient Population: Adults, Pediatrics
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Medication: Antifungal Drugs, Topical Treatments, Systemic Treatments
2) By Surgery: Surgical Debridement, Organ Removal
3) By Other Treatments: Probiotics, Home Remedies, Lifestyle Modifications
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/candidiasis-therapeutics-global-market-report
Which Geographic Area Leads the Candidiasis Therapeutics Market?
North America was the largest region in the candidiasis therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candidiasis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Is Covered In The Candidiasis Therapeutics Global Market Report?
- Market Size Analysis: Analyze the Candidiasis Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Candidiasis Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Candidiasis Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Candidiasis Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13182
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release A Deep Dive into Candidiasis Therapeutics Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034 here
News-ID: 3848437 • Views: …
More Releases from The Business Research Company
Emerging Markets And Increasing Disposable Income Fueling Diamond Market Growth: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Diamond Market Through 2025?
In the past few years, there has been a stable expansion in the diamond market size. The prediction is it will increase from $1.33 billion in 2024 to $1.39 billion in 2025, boasting a compound annual growth rate…
2025-2034 Nonmetallic Minerals Mining Support Activities Market Outlook: Key Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Nonmetallic Minerals Mining Support Activities Industry Market Size Be by 2025?
In the past few years, there has been a robust expansion in the size of the nonmetallic minerals mining support activities market. It is projected to escalate from $34.04 billion in 2024 to $36.55 billion…
Professional Street Sweeper Industry Outlook 2025-2029: Market Set to Cross $3.1 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Professional Street Sweeper Market Size By 2025?
The market size of professional street sweepers has seen significant expansion in the past few years. The market, predicted to rise from $2.37 billion in 2024 to $2.5 billion in 2025, boasts a compound annual growth rate (CAGR)…
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtrati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Industrial Wet Dust Collector Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust growth in the size of the industrial wet dust collector market. It is expected to swell from $1.89 billion in 2024 to $2 billion by 2025, showing a…
More Releases for Candidiasis
Candidiasis Market New Product Development & Latest Trends
Introduction
Candidiasis, a fungal infection caused by Candida species, represents a major healthcare challenge worldwide. While Candida albicans is the most common pathogen, emerging strains such as Candida auris are raising global concerns due to their high resistance to antifungal drugs. Candidiasis can affect the mouth (oral thrush), genital areas, bloodstream, and internal organs, with systemic infections often proving life-threatening, especially in immunocompromised patients.
The growing prevalence of hospital-acquired infections (HAIs), rising…
Rising Fungal Infection Rates Fueling Growth In The Candidiasis Therapeutics Mar …
The Candidiasis Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Candidiasis Therapeutics Market Size and Projected Growth Rate?
Recent years have seen consistent growth in the size of the market for candidiasis therapeutics. This is predicted to further expand from $3.19 billion…
Acute Vulvovaginal Candidiasis Market Beyond Douching: New Treatment Options Dri …
Acute Vulvovaginal Candidiasis Market worth $ 485.54 Million by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acute Vulvovaginal Candidiasis Market- by Drug Type (Clotrimazole, Nystatin, Fluconazole, , Terbinafine, Terconazole and Other Drug Types), Route of Administration (Oral, Intravenous and Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Trends, Industry Competition Analysis, Revenue and Forecast…
Recurrent Vulvovaginal Candidiasis Market - Defeating Recurrent Vulvovaginal Can …
Newark, New Castle, USA: The "Recurrent Vulvovaginal Candidiasis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Recurrent Vulvovaginal Candidiasis Market: https://www.growthplusreports.com/report/recurrent-vulvovaginal-candidiasis-market/8832
This latest report researches the industry structure,…
Candidiasis Epidemiology Insights to 2025
Publisher " Candidiasis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Candidiasis in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Candidiasis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with…
Candidiasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Candidiasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H1 2017, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape.
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin…
